Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes

被引:21
|
作者
Street, Jackie [1 ]
Stafinski, Tania [2 ]
Lopes, Edilene [3 ]
Menon, Devidas [4 ]
机构
[1] Univ Wollongong, Australian Ctr Hlth Engagement Evidence & Values, Wollongong, NSW, Australia
[2] Univ Alberta, Sch Publ Hlth, Hlth Policy & Management, HTPU, Edmonton, AB, Canada
[3] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia
[4] Univ Alberta, Sch Publ Hlth, Hlth Policy & Management, Edmonton, AB, Canada
关键词
Health technology assessment; Methodology; Community participation; Patient participation; PATIENT-INVOLVEMENT; FUNDING DECISIONS; SOCIAL VALUES; POLICY; DELIBERATION; PERSPECTIVES; CITIZENS; ENGAGEMENT; CHOICE; PARTICIPATION;
D O I
10.1017/S0266462320000094
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives The terminology used to describe community participation in Health Technology Assessment (HTA) is contested and frequently confusing. The terms patients, consumers, public, lay members, customers, users, citizens, and others have been variously used, sometimes interchangeably. Clarity in the use of terms and goals for including the different groups is needed to mitigate existing inconsistencies in the application of patient and public involvement (PPI) across HTA processes around the world. Methods We drew from a range of literature sources in order to conceptualize (i) an operational definition for the "public" and other stakeholders in the context of HTA and (ii) possible goals for their involvement. Draft definitions were tested and refined in an iterative consensus-building process with stakeholders from around the world. Results The goals, terminology, interests, and roles for PPI in HTA processes were clarified. The research provides rationales for why the role of the public should be distinguished from that of patients, their families, and caregivers. A definition for the public in the context of HTA was developed: A community member who holds the public interest and has no commercial, personal, or professional interest in the HTA process Conclusions There are two distinct aspects to the interests held by the public which should be explicitly included in the HTA process: the first lies in ensuring democratic accountability and the second in recognising the importance of including public values in decision making.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 50 条
  • [1] NEEDS AND RISKS ASSESSMENT IN CREATION OF HTA-INFORMED HEALTH CARE DECISION-MAKING ECOSYSTEM IN UKRAINE
    Romanenko, I
    Serediuk, V
    Zakharian, A.
    Piniazhko, O.
    Dumenko, T.
    Kahveci, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S798 - S799
  • [2] STEPS OF THE CREATION OF A HTA-INFORMED HEALTH CARE DECISION-MAKING ECOSYSTEM IN UKRAINE
    Piniazhko, O.
    Romanenko, I
    Leleka, M.
    Dudlei, M.
    Dumenko, T.
    Kahveci, R.
    Ilyk, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S797 - S797
  • [3] Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?
    Ascef, Bruna de Oliveira
    Leonel da Silva, Renan Goncalves
    de Oliveira Junior, Haliton Alves
    De Soarez, Patricia Coelho
    [J]. CADERNOS DE SAUDE PUBLICA, 2019, 35 (09):
  • [4] USING PEST ANALYSIS TO CREATE AN HTA-INFORMED HEALTH CARE DECISION- MAKING ECOSYSTEM IN UKRAINE
    Dudlei, M.
    Piniazhko, O.
    Dumenko, T.
    Malyshevska, I
    Romanenko, I
    Dvoieglazova, M.
    Lunova, O.
    Karmanova, M.
    Kahveci, R.
    Ilyk, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S805 - S805
  • [5] THE EVOLVING ROLE OF DISEASE-LEVEL PATIENT EXPERIENCE IN HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REGULATORY DECISION-MAKING
    Hudzik, A.
    Sandman, K.
    Pham, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S541 - S542
  • [6] THE ROLE OF HTA AGENCY IN DRUG REIMBURSEMENT DECISION-MAKING PROCESS IN POLAND (HTA IMPACT)
    Kolasa, K.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A251 - A251
  • [7] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A11 - A11
  • [8] SIMILARITIES AND DIFFERENCES IN HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES CONSIDERATIONS FOR DECISION-MAKING: USE OF PATIENT PREFERENCE STUDIES
    Morrison, S.
    Kumari, C.
    Castellano, G.
    Heinz, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S373 - S373
  • [9] ENVIRONMENTAL SUSTAINABILITY IN HTA: ARE HTA BODIES APPLYING ENVIRONMENTAL CRITERIA IN THEIR DECISION-MAKING?
    Szawara, P.
    Chu, J.
    Lekhwar, P.
    Dimitrova, L.
    Wagner, P.
    Van Engen, A.
    Ramachandran, K.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S376 - S376
  • [10] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT AGENCIES (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A377 - A377